Patent · US Active

Universal carrier for targeting molecules to GB3 receptor expressing cells

US9603923B2 · kind B2 · utility

0Cited by

19References

11Claims

0Family size

Assignees

INSTITUT CURIE · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
Universite Pierre Et Marie Curie (Paris 6) · FR

Inventors

Ludger Johannes · Courbevoie, FR
Eric TARTOUR · Paris, FR
Bruno Goud · Paris, FR
Wolf Herve Fridman · Paris, FR

Key dates

Filing date	Sep 5, 2014
Grant date	Mar 28, 2017
Priority date	—
Expiry date	Sep 5, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention concerns an universal polypeptidic carrier for targeting directly or indirectly a molecule to Gb3 receptor expressing cells and having the following formula STxB-Z(n)-Cys, wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.